Invention Grant
US08389526B2 3-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivatives
有权
3-杂芳基甲基 - 咪唑并[1,2-b]哒嗪-6-基衍生物
![3-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivatives](/docs/US/2013-03-05/US08389526B2/abs.jpg.600x600.jpg)
- Patent Title: 3-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivatives
- Patent Title (中): 3-杂芳基甲基 - 咪唑并[1,2-b]哒嗪-6-基衍生物
-
Application No.: US12849642Application Date: 2010-08-03
-
Publication No.: US08389526B2Publication Date: 2013-03-05
- Inventor: Pascal Furet , Clive McCarthy , Joseph Schoepfer , Stefan Stutz
- Applicant: Pascal Furet , Clive McCarthy , Joseph Schoepfer , Stefan Stutz
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent Scott W. Reid
- Main IPC: A01N43/58
- IPC: A01N43/58 ; A61K31/50 ; C07D487/00
![3-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivatives](/abs-image/US/2013/03/05/US08389526B2/abs.jpg.150x150.jpg)
Abstract:
The invention relates to compounds of formula (I) and salts thereof wherein the substituents are as defined in the specification, the application of a compound of formula (I) in a process for the treatment of the human or animal body, in particular with regard to C-Met tyrosine kinase mediated disease; the use of a compound of formula (I) for manufacturing a medicament for the treatment of such diseases; pharmaceutical compositions comprising a compound of the formula (I), optionally in the presence of a combination partner; processes for the preparation of a compound of formula (I).
Public/Granted literature
- US20110039831A1 3-HETEROARYLMETHYL-IMIDAZO[1,2-B]PYRIDAZIN-6-YL DERIVATIVES Public/Granted day:2011-02-17
Information query
IPC分类:
